Neuroleptic actions on the thyroid axis: different effects of clozapine and haloperidol

Int Clin Psychopharmacol. 1991 Winter;6(3):133-9.

Abstract

Twenty-six in-patients treated for schizophrenia, were divided in two groups. The first group received haloperidol, 20-40 mg p.d., and the second, clozapine, 150-250 mg p.d. TRH-TSH test was performed by injecting 0.2 mg TRH. Four drug-free schizophrenic patients gave normal TSH response to TRH, as well as the group of patients treated with haloperidol. Contrary to that, the clozapine-treated group showed a blunted TSH response. The results obtained are discussed in terms of the different pharmacological profiles of haloperidol and clozapine, especially regarding their dopaminergic actions, alpha-adrenergic and serotonergic control upon thyroid axis.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Clozapine / adverse effects*
  • Clozapine / therapeutic use
  • Female
  • Haloperidol / adverse effects*
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Schizophrenia, Paranoid / blood
  • Schizophrenia, Paranoid / drug therapy*
  • Schizophrenic Psychology*
  • Thyroid Function Tests*
  • Thyrotropin / blood
  • Thyrotropin-Releasing Hormone
  • Thyroxine / blood
  • Triiodothyronine / blood

Substances

  • Triiodothyronine
  • Thyrotropin-Releasing Hormone
  • Thyrotropin
  • Clozapine
  • Haloperidol
  • Thyroxine